Access cutting-edge lung cancer treatment through this clinical trial at a research site in Austin. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Austin at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and change in disease activity when telisotuzumab adizutecan is given in combination with a fixed dose of osimertinib (Osi), Osi alone, or standard of care (SOC) alone. Telisotuzumab adizutecan is an investigational drug being developed for the treatment of NSCLC. Osi is a drug approved for the treatment of NSCLC. This st
Sponsor: AbbVie
Check if you qualify for this lung cancer clinical trial in Austin, TX
If you're searching for lung cancer treatment options in Austin, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Austin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.